Immunodiagnostics Market Report, Trends, Drivers and Growth Opportunities 2022-2027
According to IMARC Group latest report titled “Immunodiagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on immunodiagnostic market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global immunodiagnostics market size reached US$ 16.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 25.2 Billion by 2027, exhibiting a growth rate (CAGR) of 7.8% during 2022-2027.
Immunodiagnostics is a type of in-vitro diagnostic method that uses antibodies, antigens, and other proteins to diagnose infectious and chronic diseases. It is a powerful tool used to detect and identify a disease’s cause and monitor its progression in order to assist in the development of treatments and vaccines. Additionally, it comprises the use of fluorescent, radiological, or color-forming enzymes and probes to identify antibodies that aid in improving the targeting range for disease progression identification. It also utilizes various instruments, reagents, and software-based solutions for chemiluminescence, rapid testing, enzyme-linked immunosorbent assay, and radioimmunoassay. Moreover, it is used to detect antibodies to specific antigens, as well as to determine the levels of specific antibodies, antigens, and proteins in the body.
Request to Get the Free Sample Report: https://www.imarcgroup.com/immunodiagnostics-market/requestsample
The escalating demand for effective diagnosis among the masses majorly drives the global market. This can be supported by the growing prevalence of infectious diseases and chronic conditions, including cancer, autoimmune diseases, Type 2 diabetes, and cardiovascular diseases due to changing lifestyles and environmental factors. Coupled with this, the rising awareness regarding the importance of early diagnosis as immunodiagnostics provide reliable and rapid diagnosis, allowing clinicians to diagnose and treat diseases before they progress is significantly supporting the market. In addition, the widespread adoption of point-of-care immunodiagnostics on account of the need for rapid and accurate diagnosis and treatment of infectious diseases, such as HIV/AIDS and sexually transmitted diseases, is impacting the market favorably. Furthermore, the emergence of personalized medicine, allowing clinicians to tailor treatments as per patients’ specific needs, is creating a positive market outlook.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/immunodiagnostics-market
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Arkray Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- Hoffmann-La Roche AG
- Immunodiagnostic Systems Holdings PLC
- Johnson & Johnson
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc
Immunodiagnostics Market Segmentation:
Our report has categorized the market based on region, product, technology, application and end use industry.
Breakup by Product:
- Software and Services
Breakup by Technology:
- Enzyme-Linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Rapid Test
Breakup by Application:
- Infectious Diseases
- Oncology and Endocrinology
- Hepatitis and Retrovirus
- Bone and Mineral
- Cardiac Biomarker
Breakup by End User:
- Clinical Laboratories
- Academic and Research Centers
- Pharmaceutical and Biotechnology Industry
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800